| Full text | |
| Author(s): |
Goncalves, Sarah S.
[1]
;
Stchigel, Alberto M.
[2]
;
Cano, Josep
[2]
;
Guarro, Josep
[2]
;
Colombo, Arnaldo L.
[1]
Total Authors: 5
|
| Affiliation: | [1] Univ Fed Sao Paulo, Dept Med, Special Mycol Lab LEMI, Sao Paulo - Brazil
[2] Univ Rovira & Virgili, Sch Med, IISPV, Mycol Unit, E-43201 Reus - Spain
Total Affiliations: 2
|
| Document type: | Journal article |
| Source: | Antimicrobial Agents and Chemotherapy; v. 57, n. 4, p. 1944-1947, APR 2013. |
| Web of Science Citations: | 20 |
| Abstract | |
The in vitro antifungal susceptibility of 77 isolates belonging to different clinically relevant species of Aspergillus section Flavi, including those of different phylogenetic clades of A. flavus, was tested for nine antifungal agents using a microdilution reference method (CLSI, M38-A2). Terbinafine and the echinocandins demonstrated lower MICs/MECs for all species evaluated, followed by posaconazole. Amphotericin B showed MICs >= 2 mu g/ml for 38 (49.4%) of the 77 isolates tested. (AU) | |
| FAPESP's process: | 12/01134-8 - Prevalence of Aspergillus species in samples from clinical/environmental origin and analysis of their susceptibility profile to six antifungals |
| Grantee: | Arnaldo Lopes Colombo |
| Support Opportunities: | Regular Research Grants |